- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01572428
Narrow-Band Imaging Versus Standard White Light for the Detection of Serrated Lesions in the Proximal Colon
June 27, 2019 updated by: Douglas K. Rex, Indiana University
Randomized Controlled Trial Comparing the Use of Narrow-Band Imaging Versus Standard White Light for the Detection of Serrated Lesions in the Proximal Colon
This is a study to determine if using Narrow-Band Imaging of the colon, rather than the usual white light on the colon, will improve the detection of a type of polyp called serrated.
The polyps are called serrated because of their appearance under the microscope after they have been removed.
They tend to be located up high in the colon, far away from the rectum.
They have been definitely shown to be a type of precancerous polyp and it is possible that using Narrow-Band Imaging will make it easier to see them, as they can be quite difficult to see with standard white light.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a randomized controlled trial comparing the use of Narrow-Band Imaging (illumination of the colon in blue light)versus standard white light for the detection of serrated lesions in the proximal colon (the colon proximal to the splenic flexure).
Recent studies have indicated that colonoscopy is more effective in preventing cancer in the left side of the colon than the right side of the colon.
The reasons for this difference may be partly biologic, in that a special group of polyps known as serrated polyps, particularly sessile serrated adenomas, are located primarily proximal to the splenic flexure.
These lesions share molecular features with a group of cancers that occur primarily in the proximal colon.
These molecular features include CpG island methylator phenotype (CIMP) and microsatellite instability.
These lesions are endoscopically subtle in that they are often flat, have the same color as the surrounding mucosa, and are hard to differentiate from normal mucosa.
Narrow-Band Imaging has anecdotally been used to highlight the appearance of these lesions.
This study will test whether Narrow-Band Imaging increases the detection of serrated lesions in a randomized controlled trial.
Study Type
Interventional
Enrollment (Actual)
898
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
Indianapolis, Indiana, United States, 46280
- Beltway Surgical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 85 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 50-85
- Intact colon and rectum
- American Society of Anesthesiology risk class 1, 2 or 3
Exclusion Criteria:
- No prior surgical resection of colon or rectum
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Narrow-Band Imaging (NBI)
Inspection with Narrow-Band Imaging(NBI) versus inspection with standard white light(usual care)
|
Narrow-Band Imaging(NBI)of the colon rather than the standard white light in the inspection of the colon during colonoscopy.
Other Names:
|
|
ACTIVE_COMPARATOR: Standard White Light
Inspection with Standard White Light versus Narrow-Band Imaging(NBI)
|
Narrow-Band Imaging(NBI)of the colon rather than the standard white light in the inspection of the colon during colonoscopy.
Other Names:
Use of Standard White Light on the colon rather than Narrow-Band Imaging(NBI)in the inspection of the colon during a colonoscopy.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total Number of Serrated Lesions Proximal to the Sigmoid Colon
Time Frame: During the colonoscopy procedure
|
Total quantity of serrated lesions found proximal to the sigmoid colon during colonoscopy.
|
During the colonoscopy procedure
|
|
Number of Serrated Lesions Proximal to the Sigmoid Colon Per Patient
Time Frame: During the colonoscopy procedure
|
Average number of polyps per patient that had serrated histology and were located proximal to the sigmoid colon (cecum to transverse colon).
|
During the colonoscopy procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patients With 1 or More Serrated Lesions Proximal to the Sigmoid Colon
Time Frame: During the colonoscopy procedure
|
Patient had to have at least 1 polyp that had serrated histology and was located proximal to the sigmoid colon (cecum to transverse colon).
|
During the colonoscopy procedure
|
|
Total Number of Conventional Adenomas in Entire Colon
Time Frame: During the colonoscopy procedure
|
Total quantity of adenomas found during colonoscopy procedure.
|
During the colonoscopy procedure
|
|
Number of Conventional Adenomas Per Patient in Entire Colon
Time Frame: During the colonoscopy procedure
|
Average number of adenomas (located anywhere throughout the colon) found per patient.
|
During the colonoscopy procedure
|
|
Patients With 1 or More Conventional Adenomas
Time Frame: During the colonoscopy procedure
|
Patient had to have at least 1 polyp that was an adenoma.
|
During the colonoscopy procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2011
Primary Completion (ACTUAL)
July 7, 2014
Study Completion (ACTUAL)
July 7, 2014
Study Registration Dates
First Submitted
July 11, 2011
First Submitted That Met QC Criteria
April 4, 2012
First Posted (ESTIMATE)
April 6, 2012
Study Record Updates
Last Update Posted (ACTUAL)
August 8, 2019
Last Update Submitted That Met QC Criteria
June 27, 2019
Last Verified
June 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1012-17
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colon Cancer
-
Chaoxi ZhouRecruitingProximal Transverse Colon Cancer | Ascending Colon CancerChina
-
Gruppo Oncologico del Nord-OvestSeagen Inc.; Servier; Foundation MedicineSuspendedStage II Colon Cancer | Stage III Colon Cancer | HER2-positive Colon Cancer | RAS Wild-type Colon CancerItaly
-
Chang Gung Memorial HospitalCompletedColon Cancer | Cancer Recurrence | Colon Adenocarcinoma | Colon Cancer Stage II | Colon Cancer Stage I | Survival Analysis | Colon Cancer Stage IIITaiwan
-
Case Comprehensive Cancer CenterCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer and other conditionsUnited States
-
National Cancer Institute (NCI)NSABP Foundation IncCompletedColon Adenocarcinoma | Stage IIIA Colon Cancer AJCC v7 | Stage IIIB Colon Cancer AJCC v7 | Stage IIIC Colon Cancer AJCC v7 | Stage IIA Colon Cancer AJCC v7 | Stage IIB Colon Cancer AJCC v7 | Stage IIC Colon Cancer AJCC v7United States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedFatigue | Depressive Symptoms | Stage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Psychosocial Effects of Cancer and Its Treatment | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage I Colon Cancer | Stage... and other conditionsUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingStage III Colon Cancer AJCC v8 | Colon Adenocarcinoma | Microsatellite Stable Colon Carcinoma | Stage IIB Colon Cancer AJCC v8 | Stage IIC Colon Cancer AJCC v8United States
-
Hospital da Senhora da OliveiraCompletedColon Cancer | Colon Adenoma | Colon Polyp | Colon Rectal CancerPortugal
-
National Cancer Institute (NCI)CompletedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer | Stage IVB Colon Cancer | Stage IVB Rectal CancerUnited States
Clinical Trials on Inspection with Narrow-Band Imaging(NBI)
-
Lotung Poh-Ai HospitalTerminated
-
Memorial Sloan Kettering Cancer CenterCompletedOvarian Cancer | Fallopian Tube Cancer | Lung Cancer | Endometrial Cancer | Peritoneal Cancer | Esophageal Carcinoma | Pancreatic Carcinoma | Gastrointestinal CarcinomaUnited States
-
Yonsei UniversityUnknownEarly Gastric Cancer | Gastric Dysplasia | Gastric Adenoma
-
Mercy Medical CenterAdvocate Lutheran General Hospital; Olympus America, Inc.CompletedEndometriosisUnited States
-
Tomasz RomańczykCompletedHeterotopic Gastric Mucosa of the Proximal EsophagusPoland
-
Parc de Salut MarCompleted
-
Seoul National University HospitalCompletedIntestinal PolypsKorea, Republic of
-
Chinese PLA General HospitalUnknown
-
University of CambridgeUnknownBarrett EsophagusUnited Kingdom
-
Renmin Hospital of Wuhan UniversityShandong University; Shengjing Hospital; Guizhou Provincial People's Hospital; Air... and other collaboratorsRecruitingColorectal Adenoma | Artificial Intelligence (AI)China